Épistémê Entrepreneur

ITW Dr. Ivan De Weber, PhD - Cofounder-CEO at Cortex Discovery👉https://www.linkedin.com/events/itwdrivandeweber-cofounder-ceoa7258560211001511937/theater/Exciting news! 🚀 Join us for the next episode of our LinkedIn Live podcast featuring Dr. Ivan De Weber, PhD Weber, co-founder and CEO of Cortex Discovery, a groundbreaking startup revolutionizing drug discovery through AI!🔬 From Academia to AI-Powered Drug DiscoveryDr. de Weber's journey is nothing short of inspiring. We'll explore his transition from cellular biology and pharmaceutical bioinformatics to founding a company at the cutting edge of AI-driven drug discovery. Learn how his lifelong quest for longevity research led to the creation of Cortex Discovery.🧠 Unveiling Cortex Discovery's Innovative ApproachDiscover how Cortex Discovery is disrupting preclinical drug discovery across all therapeutic areas with their proprietary AI models. We'll delve into:• Their foundation model for drug property predictions• The vast database of 750 million data points powering their deep learning system• Recent breakthroughs, including the first AI-discovered compound proven to extend lifespan in a whole organism💼 Business Insights and Future OutlookGet an insider's perspective on:• Cortex Discovery's unique business model and collaboration opportunities• Challenges faced in the AI-driven drug discovery landscape• The company's vision for the future of longevity research and pharmaceutical developmentThis episode is a must-watch for:• Biotech and pharmaceutical executives• Investors in the life sciences sector• Academic researchers in pharmaceutical chemistry, longevity biology, and clinical medicine• Anyone interested in the intersection of AI and drug discoveryDon't miss this opportunity to gain valuable insights into the future of AI-powered drug discovery and longevity research. Tune in to our LinkedIn Live podcast and be part of the conversation shaping the future of medicine!👉https://www.linkedin.com/events/itwdrivandeweber-cofounder-ceoa7258560211001511937/theater/

ITW Dr. Ivan De Weber, PhD - Cofounder-CEO at Cortex Discovery👉https://www.linkedin.com/events/itwdrivandeweber-cofounder-ceoa7258560211001511937/theater/Exciting news! 🚀 Join us for the next episode of our LinkedIn Live podcast featuring Dr. Ivan De Weber, PhD Weber, co-founder and CEO of Cortex Discovery, a groundbreaking startup revolutionizing drug discovery through AI!🔬 From Academia to AI-Powered Drug DiscoveryDr. de Weber's journey is nothing short of inspiring. We'll explore his transition from cellular biology and pharmaceutical bioinformatics to founding a company at the cutting edge of AI-driven drug discovery. Learn how his lifelong quest for longevity research led to the creation of Cortex Discovery.🧠 Unveiling Cortex Discovery's Innovative ApproachDiscover how Cortex Discovery is disrupting preclinical drug discovery across all therapeutic areas with their proprietary AI models. We'll delve into:• Their foundation model for drug property predictions• The vast database of 750 million data points powering their deep learning system• Recent breakthroughs, including the first AI-discovered compound proven to extend lifespan in a whole organism💼 Business Insights and Future OutlookGet an insider's perspective on:• Cortex Discovery's unique business model and collaboration opportunities• Challenges faced in the AI-driven drug discovery landscape• The company's vision for the future of longevity research and pharmaceutical developmentThis episode is a must-watch for:• Biotech and pharmaceutical executives• Investors in the life sciences sector• Academic researchers in pharmaceutical chemistry, longevity biology, and clinical medicine• Anyone interested in the intersection of AI and drug discoveryDon't miss this opportunity to gain valuable insights into the future of AI-powered drug discovery and longevity research. Tune in to our LinkedIn Live podcast and be part of the conversation shaping the future of medicine!👉https://www.linkedin.com/events/itwdrivandeweber-cofounder-ceoa7258560211001511937/theater/

ITW Dr. Ivan De Weber, PhD - Cofounder-CEO at Cortex Discovery👉https://www.linkedin.com/events/itwdrivandeweber-cofounder-ceoa7258560211001511937/theater/Exciting news! 🚀 Join us for the next episode of our LinkedIn Live podcast featuring Dr. Ivan De Weber, PhD Weber, co-founder and CEO of Cortex Discovery, a groundbreaking startup revolutionizing drug discovery through AI!🔬 From Academia to AI-Powered Drug DiscoveryDr. de Weber's journey is nothing short of inspiring. We'll explore his transition from cellular biology and pharmaceutical bioinformatics to founding a company at the cutting edge of AI-driven drug discovery. Learn how his lifelong quest for longevity research led to the creation of Cortex Discovery.🧠 Unveiling Cortex Discovery's Innovative ApproachDiscover how Cortex Discovery is disrupting preclinical drug discovery across all therapeutic areas with their proprietary AI models. We'll delve into:• Their foundation model for drug property predictions• The vast database of 750 million data points powering their deep learning system• Recent breakthroughs, including the first AI-discovered compound proven to extend lifespan in a whole organism💼 Business Insights and Future OutlookGet an insider's perspective on:• Cortex Discovery's unique business model and collaboration opportunities• Challenges faced in the AI-driven drug discovery landscape• The company's vision for the future of longevity research and pharmaceutical developmentThis episode is a must-watch for:• Biotech and pharmaceutical executives• Investors in the life sciences sector• Academic researchers in pharmaceutical chemistry, longevity biology, and clinical medicine• Anyone interested in the intersection of AI and drug discoveryDon't miss this opportunity to gain valuable insights into the future of AI-powered drug discovery and longevity research. Tune in to our LinkedIn Live podcast and be part of the conversation shaping the future of medicine!👉https://www.linkedin.com/events/itwdrivandeweber-cofounder-ceoa7258560211001511937/theater/

LLMs vs. NLP: A ClarificationUnderstanding the AI LandscapeArtificial Intelligence (AI) has made significant strides in recent years, especially in the field of natural language processing (NLP). A particular subset of NLP, Large Language Models (LLMs), has garnered much attention due to their impressive capabilities. However, it's important to understand the relationship between these two concepts.NLP: The FoundationNatural Language Processing (NLP) is a branch of AI that focuses on the interaction between computers and human language. It encompasses various techniques that enable machines to understand, interpret, and generate human language. NLP tasks include: Text Analysis: Breaking down text into smaller units, such as words and sentences.Sentiment Analysis: Determining the emotional tone of text, whether it's positive, negative, or neutral.Machine Translation: Translating text from one language to another.Text Summarization: Condensing long pieces of text into shorter summaries.Question Answering: Providing answers to questions posed in natural language.LLMs: A Powerful ToolLarge Language Models (LLMs) are a specific type of AI model that has been trained on massive amounts of text data. This training enables them to generate human-quality text, translate languages, write different kinds of creative content, and answer your questions in an informative way. LLMs are a powerful tool within the NLP toolkit, but they are not a replacement for all NLP techniques. The Relationship Between LLMs and NLPTo clarify the relationship between LLMs and NLP, consider the following analogy:NLP is like a toolbox filled with various tools, each designed for specific tasks.LLMs are a powerful tool within this toolbox, capable of performing a wide range of tasks, but they are not the only tool available.While LLMs excel at tasks like text generation and question answering, traditional NLP techniques may be more suitable for other tasks, such as sentiment analysis or information extraction.The Broader AI LandscapeBoth NLP and LLMs are subsets of a larger field, Machine Learning (ML). ML is a branch of AI that involves training algorithms on data to make predictions or decisions. Other key branches of ML include:Computer Vision: Enabling machines to understand and interpret visual information.Reinforcement Learning: Training agents to make decisions by interacting with an environment.Unsupervised Learning: Discovering hidden patterns in data without explicit labels.ConclusionLLMs are a significant advancement in the field of NLP, but they are not a replacement for all NLP techniques. Instead, they complement and enhance the existing tools available to AI researchers and developers. By understanding the relationship between LLMs and NLP, we can better appreciate their potential and limitations, and apply them effectively to solve real-world problems.

ITW Kamyar Maserrat - Intellectual Property Lawyer | Senior Counsel at Foley & Lardner LLP | Expert in Deeptech🚀 Unveiling the Future of Deep Tech: Join Us for an Exclusive Chat with IP Guru Kamyar Maserrat! 🚀🌟 Calling all scientists, engineers, tech startup founders, and VCs! 🌟Are you ready to dive into the thrilling world of deep tech and intellectual property? We've got an episode that you absolutely CANNOT miss! 🎬Join us for an electrifying conversation with Kamyar Maserrat, Senior Counsel at Foley & Lardner LLP and a true IP wizard in the realms of AI, robotics, and quantum tech. Kamyar's journey from civil engineer to leading IP lawyer is nothing short of inspiring, and his insights are pure gold for anyone navigating the complex landscape of deep tech innovation.💡 Why You Need to Watch This Episode:Unraveling IP Complexity: Kamyar breaks down the intricate world of intellectual property, making it accessible and actionable for startups and innovators.AI and Quantum Revolution: Discover the latest trends and challenges in AI and quantum technology, and how they're reshaping the future of tech.Strategic IP Advantage: Learn how a robust IP strategy can be your secret weapon in securing venture capital funding and gaining a competitive edge.Global IP Chess Game: Get insider tips on navigating the global IP landscape and protecting your innovations across borders.Future of IP in Deep Tech: Kamyar shares his predictions on the future of IP in deep tech, including collaborative IP models and the role of AI in the patent process.🎯 Who Should Watch:Tech Startup Founders: Gain invaluable insights into protecting your innovations and attracting investors.Scientists and Engineers: Understand the legal landscape of deep tech and how to safeguard your groundbreaking work.Venture Capitalists: Learn what to look for in a startup's IP portfolio to make smarter investment decisions.This episode is a must-watch for anyone looking to stay ahead in the fast-paced world of deep tech. Whether you're a seasoned entrepreneur or an aspiring innovator, Kamyar's expertise will equip you with the knowledge and strategies you need to succeed.For more insights into the world of IP law and deep tech, be sure to check out Kamyar's blog, "Beyond the Binary," at Foley & Lardner LLP. And for a deeper dive into the fascinating world of quantum technology, Kamyar recommends the book "Quantum Supremacy" by Michio Kaku.Kamyar's LinkedInhttps://www.linkedin.com/in/kamyar-maserrat-6118908/Beyond The Binary: https://www.foley.com/insights/publications/2024/04/beyond-binary-legal-considerations-quantum-computing-era/https://www.foley.com/

From Robotics Engineer to Sales Guru: The Fascinating Journey of Darius LahoutifardIn the world of tech entrepreneurship and sales methodology, few names shine as brightly as Darius Lahoutifard. But how did a math-loving, robotics engineer from Iran become a best-selling author and the driving force behind MEDDIC Academy? Buckle up, because this story is as captivating as it is inspiring!The Shocking Career PivotImagine the horror of Darius's family and friends when he announced his decision to switch to sales. In their eyes, he might as well have declared he was running away to join the circus! But our intrepid hero was undeterredFrom Sales Success to MEDDIC MastermindDarius's unconventional approach to sales – combining his engineering problem-solving skills with a deep understanding of customer needs – proved to be a winning formula. He skyrocketed through the ranks, becoming a CEO at the tender age of 28 and leading his unit at PTC from $4M to $27M in just three years.It was during his time at PTC that Darius, along with other sales leaders, laid the foundation for what would become the MEDDIC and MEDDPICC sales methodologies – now industry standards for complex B2B sales.The Cyrus Connection: Ancient Wisdom for Modern LeadersSo, what does all this have to do with Cyrus the Great, the ancient Persian king? As it turns out, everything! Darius's latest book, "Leadership by Cyrus the Great, Unlocking Xenophon's Cyropaedia," brings the timeless wisdom of this historical figure to today's business leaders.Drawing parallels between his own journey and the teachings of Cyrus, Darius offers a unique perspective on leadership that combines ancient philosophy with modern business acumen. It's like "The Art of War" meets "How to Win Friends and Influence People," but with a Persian twist!Why Executives Should CareIn a world where leadership books are a dime a dozen, Darius Lahoutifard's offering stands out. Here's why executives should pay attention:Proven Track Record: Darius isn't just theorizing – he's walked the walk, from engineer to CEO to successful entrepreneur.Unique Perspective: The blend of ancient wisdom and modern business practices offers fresh insights for today's leaders.Cross-Cultural Appeal: In an increasingly globalized business world, Darius's international background and the universal principles of Cyrus's leadership are more relevant than ever. So, whether you're a seasoned CEO or an aspiring leader, take a page from Darius Lahoutifard's book (literally!). After all, if a mathematician can become a sales superstar by channelling the wisdom of an ancient Persian prince from a tiny kingdom who went on to become the greatest emperor in the history of mankind, imagine what you can resources we have now!Become a Great Leader Now https://lire.amazon.fr/kp/embed?asin=B0DDP1NBM9&preview=newtab&linkCode=kpe&ref_=kip_embed_taf_preview_HJ2DZ1KHFSRNZ3TPYTFT&tag=arimContact Dariushttps://www.linkedin.com/in/meddic/https://meddic.academy

From Quantum Physics to Anti-Counterfeiting: The Fascinating Journey of Dr. Fred JordanIn the world of tech entrepreneurship, few stories are as captivating as that of Dr. Fred Jordan, co-founder and CEO of AlpVision. His journey from a quantum physics enthusiast to a pioneer in anti-counterfeiting technology is not just inspiring—it's downright fascinating.From Academia to EntrepreneurshipTheir professor at EPFL planted the seed of entrepreneurship in their mind. With no startup ecosystem to support them, Fred and his co-founder Martin ventured into the unknown, armed with nothing but their technology and a dream.The Birth of a Game-Changing TechnologyDuring their PhD, Fred and Martin stumbled upon digital watermarking—a technology that would change the course of his career. Imagine hiding secret messages in images, invisible to the naked eye but detectable by computers. It's like spy tech meets art!The early days of AlpVision were fraught with challenges. With limited funding and no clients, Fred and his team had to innovate and adapt. They created multiple demonstration systems, each tailored to different industries, and eventually found their breakthrough with a bank that needed a solution to prevent tampering with invoices. This success paved the way for more clients and opened doors to new opportunities.The Yellow Dot BreakthroughBut the real game-changer came when they discovered they could print invisible yellow dots on white paper, detectable only by document scanners. This innovation opened up a world of possibilities in anti-counterfeiting technology.The Business ModelOne of the key factors contributing to AlpVision's success is its unique business model. Instead of charging clients for the technology upfront, AlpVision operates on a royalty-based model. Clients pay for the right to print a certain number of patterns, and this recurring revenue stream ensures a steady income for the company. This model not only benefits AlpVision but also provides a cost-effective solution for clients, as there are no material costs involved.The TechnologyAlpVision's technology is rooted in mathematics, specifically image cross-correlation. This mathematical technique allows for the reliable detection of hidden patterns, even in noisy environments. The company has adapted this technology to various industries, from pharmaceuticals to luxury goods, providing invisible and reliable authentication solutions.One of the most fascinating applications of AlpVision's technology is in the detection of counterfeit products using smartphones. Initially, the company faced skepticism about the feasibility of detecting microscopic patterns with a handheld device. However, through innovative approaches and real-time processing, AlpVision has made this a reality. The technology can now detect genuine products within seconds, making it an invaluable tool for brand protection.ConclusionAlpVision's journey is a testament to the power of innovation, perseverance, and a customer-centric approach. By leveraging cutting-edge technology and a unique business model, the company has not only protected countless brands from counterfeiting but also carved a successful path in the tech industry. As the fight against counterfeiting continues, companies like AlpVision are leading the charge, ensuring that businesses and consumers alike can trust the authenticity of the products they buy.https://alpvision.com/https://www.linkedin.com/in/fred-jordan-anticounterfeiting-brandprotection-authentication/-----Co-host: Dr. Benjamin DELSOL, Quantum Physicist, European Patent Attorney, Expert Deep Tech Innovation / DELSOL https://www.linkedin.com/in/benjamindelsol/

ITW Dr. Fred Jordan, CEO of FinalSpark!  Swiss Startup Revolutionizing AI with Human Neurons. 🧠into🤖The Future of Computing is Here and Alive: Join the FinalSpark RevolutionFinalSpark, a Swiss startup, is pioneering biocomputing by leveraging living neurons to develop advanced computational systems. Led by visionary Dr. Fred Jordan, FinalSpark cultivates human-derived neuro-organoids that mimic the brain and connects them to in silico systems.Biocomputers could be a million times more energy-efficient than traditional AI, reducing environmental impact.FinalSpark's groundbreaking platform is already used by 9 universities globally for cutting-edge biocomputing research. However, scaling up requires overcoming challenges like growing and maintaining large neuron networks.The team behind FinalSpark is as impressive as its vision. Dr. Fred Jordan and Dr. Martin Kutter are joined by a diverse group of experts, including biologists, engineers, and advisors with decades of experience. This multidisciplinary approach ensures that FinalSpark is not just a tech company but a hub of innovation where different fields converge to create something extraordinary.This is an opportunity to be part of a revolution:Deep tech investors: FinalSpark is ready to accelerate R&D in this potentially world-changing technology.Neurobiologists: Contribute to pioneering research bridging biology and tech by collaborating on FinalSpark's work with hippocampal organoids and memory.Technologists: With open access and Python programmability, FinalSpark's platform offers a playground for innovation in algorithms, models, and more.The FinalSpark adventure demands vision, collaboration and pushing boundaries. Are you ready to join and create a future where machines think and learn?----Co-host: Dr. Benjamin DELSOL, Quantum Physicist, European Patent Attorney, Expert Deep Tech Innovation / DELSOL

Découvrez l'Art de la Communication Efficace avec Audrey Degail, experte en Process Communication Model (PCM). Fondatrice de LINE, elle accompagne les entreprises et leurs équipes pour optimiser leur communication. Dans cet épisode d'E², Audrey partage son parcours inspirant, marqué par une expérience dans le secteur public et une quête de sens et de liberté.Elle découvre alors le PCM, un outil puissant développé par le Dr. Taibi Kahler, initialement utilisé par la NASA. Il permet de comprendre et d'améliorer les interactions humaines en identifiant les types de personnalités et leurs modes de communication. Pour Audrey, c'est un effet 'waouh', une révélation sur elle-même et les autres.Elle souligne l'importance de la communication interpersonnelle, différente selon les cultures. En France, elle est souvent vue comme unidirectionnelle, alors qu'aux États-Unis, elle est perçue comme un échange interactif. Audrey insiste sur le fait que la communication efficace nécessite que les deux parties soient sur le même canal.Le PCM est utilisé par Audrey pour aider les entreprises à améliorer leur communication interne, que ce soit pour résoudre des conflits ou faciliter les transitions. C'est aussi un outil de développement personnel, permettant de mieux se comprendre et comprendre les autres.Rencontrer Audrey et découvrir le PCM est une expérience enrichissante. Son parcours et sa passion pour la communication sont contagieux. Si vous êtes intéressé par l'amélioration de vos compétences en communication, nous vous encourageons à explorer le PCM. Pour en savoir plus sur Audrey et le PCM, suivez ses interventions.Audrey Degail | LinkedInLINE I workshops I associés I degail I bordeaux (just-line.fr)Livres recommandés par AudreyPCM en interaction : Se connecter à soi-même et aux autres (Accompagnement et Coaching)https://amzn.eu/d/bCFBmO6L'Intelligence intimehttps://amzn.eu/d/8P8GX1ALe podcast de Maud Ankaoua recommandé par Audreyhttps://www.maud-ankaoua.com/podcast.php